Kidney Disease Clinical Trials in Chicago

Showing 161-180 of 220 trials

Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

NCT00727532

RATIONALE: Sorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. Giving sorafenib before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. PURPOSE: This clinical trial is studying how well sorafenib works in treating patients with locally advanced or metastatic kidney cancer.

Hereditary Clear Cell Renal Cell CarcinomaKidney Cancer

Northwestern University9 participantsStarted Jul 2008

Chicago, Illinois, United States

TERMINATEDPHASE12.2 miles

Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction

NCT01907802

This phase I trial studies the side effects and best dose of dabrafenib in treating patients with solid tumors and kidney or liver dysfunction. Dabrafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

BRAF Gene MutationHepatic ComplicationRenal Failure+1 more

National Cancer Institute (NCI)8 participantsStarted Aug 2013

Duarte, California, United States • Los Angeles, California, United States • Sacramento, California, United States +15 more locations

Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction

Kidney Disease Trials in Other Cities

A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin

Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1

Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)

A Study of LY2928057 in Hemodialysis Participants

A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)

Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Continued Access Study

Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study

Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients

Registry to Evaluate Maintenance Treatment With Venofer in Pediatric Patients With Chronic Kidney Disease

VEG111485: A QTc Study of Pazopanib

Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Multiple Myeloma and Renal Disease

A Single-dose Study in Paediatric Patients Aged 2 to Less Than 18 Years With Secondary Hyperparathyroidism (sHPT) Receiving Haemodialysis

A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT

Propaten Randomized Investigation on Cost-benefit and Efficacy

Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer

A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors

Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD

Other Conditions in Chicago